CSS LLC’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,100
Closed -$8K 952
2022
Q3
$8K Sell
1,100
-2,800
-72% -$24.2K ﹤0.01% 978
2022
Q2
$39K Buy
3,900
+2,800
+255% +$31.3K ﹤0.01% 965
2022
Q1
$14K Sell
1,100
-50,000
-98% -$773K ﹤0.01% 1087
2021
Q4
$1.17M Sell
51,100
-17,600
-26% -$417K 0.04% 381
2021
Q3
$1.52M Buy
+68,700
New +$1.09M 0.06% 314
2020
Q4
Sell
-10,000
Closed -$147K 817
2020
Q3
$147K Buy
10,000
+4,100
+69% +$59.4K 0.01% 610
2020
Q2
$96K Buy
+5,900
New +$94.5K 0.01% 553

Other funds holding AUPH

CSS LLC's AUPH Position: Q4 2022 in Review

CSS LLC sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2022, closing a stake of 27,338 shares — an estimated $206K sold.

CSS LLC first reported a position in AUPH in Q4 2019 and held it in 12 quarters. The position peaked at $1.22M in Q3 2021. 191 funds tracked by Wall St. Rank hold AUPH as of Q4 2022.

  • CSS LLC reported no remaining Aurinia Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • CSS LLC sold 27,338 Aurinia Pharmaceuticals shares in Q4 2022, an estimated $206K.
  • CSS LLC first reported a position in Aurinia Pharmaceuticals in Q4 2019 and held it in 12 quarters.
  • CSS LLC's Aurinia Pharmaceuticals position peaked at $1.22M in Q3 2021.
  • 191 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2022.

Based on CSS LLC's 13F filing for Q4 2022, filed 14 Feb 2023.